• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用18F-FDG PET监测非小细胞肺癌化疗反应的方法。

Methods to monitor response to chemotherapy in non-small cell lung cancer with 18F-FDG PET.

作者信息

Hoekstra Corneline J, Hoekstra Otto S, Stroobants Sigrid G, Vansteenkiste Johan, Nuyts Johan, Smit Egbert F, Boers Maarten, Twisk Jos W R, Lammertsma Adriaan A

机构信息

Clinical PET Centre, VU University Medical Centre, Amsterdam, The Netherlands.

出版信息

J Nucl Med. 2002 Oct;43(10):1304-9.

PMID:12368367
Abstract

UNLABELLED

PET using 18F-FDG is a promising technique to monitor response in oncology. Unfortunately, a multitude of analytic methods is in use. To date, it is not clear whether simplified methods could replace complex quantitative methods in routine clinical practice. The aim of this study was to select those methods that would qualify for further assessment in a future prospective response-monitoring study by comparing results with patient outcome.

METHODS

Dynamic 18F-FDG PET scans were obtained on 2 groups of patients. First, 10 patients with advanced non-small cell lung cancer (NSCLC) were scanned on consecutive days before treatment to assess test-retest variability. Second, 30 scans were obtained on 19 patients with locally advanced NSCLC as part of an ongoing response-monitoring study. These scans were analyzed by 2 observers to assess observer variability. In addition, these studies were used to compare various methods with the gold standard, full kinetic analysis (nonlinear regression [NLR]).

RESULTS

Using an image-derived input function, NLR showed excellent test-retest and observer agreement confirming that it could be used as a gold standard method. From a total of 34 analytic methods, 10 showed good correlation with NLR. Taking into account the degree of complexity of the methods, 4 remain for further evaluation.

CONCLUSION

The optimal method for analysis of 18F-FDG PET data was determined for several levels of complexity. Four methods need to be evaluated further to determine the optimal trade-off between simplicity and accuracy for routine clinical practice.

摘要

未标注

使用18F-FDG的PET是监测肿瘤学中反应的一种有前景的技术。不幸的是,目前使用着多种分析方法。迄今为止,尚不清楚在常规临床实践中简化方法是否能够取代复杂的定量方法。本研究的目的是通过将结果与患者预后进行比较,选择那些有资格在未来前瞻性反应监测研究中进行进一步评估的方法。

方法

对两组患者进行了动态18F-FDG PET扫描。首先,对10例晚期非小细胞肺癌(NSCLC)患者在治疗前连续几天进行扫描,以评估重测变异性。其次,作为正在进行的反应监测研究的一部分,对19例局部晚期NSCLC患者进行了30次扫描。这两名观察者对这些扫描进行分析,以评估观察者间的变异性。此外,这些研究还用于将各种方法与金标准——全动力学分析(非线性回归[NLR])进行比较。

结果

使用图像衍生输入函数时,NLR显示出极好的重测一致性和观察者间一致性,证实其可作为金标准方法。在总共34种分析方法中,有10种与NLR显示出良好的相关性。考虑到这些方法的复杂程度,有4种方法有待进一步评估。

结论

针对几种复杂程度确定了分析18F-FDG PET数据的最佳方法。有4种方法需要进一步评估,以确定在常规临床实践中简单性和准确性之间的最佳权衡。

相似文献

1
Methods to monitor response to chemotherapy in non-small cell lung cancer with 18F-FDG PET.用18F-FDG PET监测非小细胞肺癌化疗反应的方法。
J Nucl Med. 2002 Oct;43(10):1304-9.
2
Chemotherapy response evaluation with 18F-FDG PET in patients with non-small cell lung cancer.18F-FDG PET对非小细胞肺癌患者化疗反应的评估
J Nucl Med. 2007 Oct;48(10):1592-8. doi: 10.2967/jnumed.107.043414. Epub 2007 Sep 14.
3
Repeat 18F-FDG PET for monitoring neoadjuvant chemotherapy in patients with stage III non-small cell lung cancer.重复进行18F-FDG PET以监测III期非小细胞肺癌患者的新辅助化疗。
Lung Cancer. 2007 Feb;55(2):165-71. doi: 10.1016/j.lungcan.2006.09.028. Epub 2006 Nov 28.
4
18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer.18F-FDG摄取作为手术切除的非小细胞肺癌患者复发的生物学预后因素。
J Nucl Med. 2002 Jan;43(1):39-45.
5
Time course of early response to chemotherapy in non-small cell lung cancer patients with 18F-FDG PET/CT.非小细胞肺癌患者接受18F-FDG PET/CT检查后对化疗早期反应的时间进程
J Nucl Med. 2007 May;48(5):744-51. doi: 10.2967/jnumed.106.038513.
6
Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer.[18F]-2-氟-2-脱氧-D-葡萄糖正电子发射断层扫描在局部晚期非小细胞肺癌患者中进行疗效评估的预后相关性
J Clin Oncol. 2005 Nov 20;23(33):8362-70. doi: 10.1200/JCO.2005.01.1189.
7
Use of a dual-head coincidence camera and 18F-FDG for detection and nodal staging of non-small cell lung cancer: accuracy as determined by 2 independent observers.使用双头符合相机和18F-FDG进行非小细胞肺癌的检测和淋巴结分期:由两名独立观察者确定的准确性。
J Nucl Med. 2003 Mar;44(3):336-40.
8
Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use.正电子发射断层扫描在非小细胞肺癌中的应用:通过葡萄糖利用的定量评估预测化疗反应
J Clin Oncol. 2003 Jul 15;21(14):2651-7. doi: 10.1200/JCO.2003.12.004.
9
Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.放疗前PET/CT上18F-FDG高摄取区域可确定非小细胞肺癌放化疗后局部复发的优先部位。
J Nucl Med. 2015 Feb;56(2):196-203. doi: 10.2967/jnumed.114.144253. Epub 2015 Jan 8.
10
Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.动态18F-FDG PET中基于葡萄糖代谢率图和SUV图得出的肿瘤体积比较。
J Nucl Med. 2008 Jun;49(6):892-8. doi: 10.2967/jnumed.107.049585. Epub 2008 May 15.

引用本文的文献

1
Improving accuracy of SUV estimates in paediatric oncology: Recommending against the use of body weight corrected SUV in [F]FDG PET.提高儿科肿瘤学中SUV估计值的准确性:建议在[F]FDG PET中不使用体重校正的SUV
Eur J Nucl Med Mol Imaging. 2025 Jun;52(7):2444-2451. doi: 10.1007/s00259-025-07104-6. Epub 2025 Feb 8.
2
Feasibility study of a SiPM-fiber detector for non-invasive measurement of arterial input function for preclinical and clinical positron emission tomography.用于临床前和临床正电子发射断层扫描动脉输入函数无创测量的硅光电倍增管 - 光纤探测器的可行性研究。
EJNMMI Phys. 2024 Jan 31;11(1):12. doi: 10.1186/s40658-024-00618-2.
3
The clinical value of quantitative cardiovascular molecular imaging: a step towards precision medicine.
定量心血管分子成像的临床价值:迈向精准医学的一步。
Br J Radiol. 2023 Dec;96(1152):20230704. doi: 10.1259/bjr.20230704. Epub 2023 Oct 24.
4
Optimization of BMI-Based Images for Overweight and Obese Patients - Implications on Image Quality, Quantification, and Radiation Dose in Whole Body F-FDG PET/CT Imaging.基于体重指数的超重和肥胖患者图像优化——对全身F-FDG PET/CT成像中图像质量、定量分析及辐射剂量的影响
Nucl Med Mol Imaging. 2023 Aug;57(4):180-193. doi: 10.1007/s13139-023-00795-5. Epub 2023 Mar 20.
5
Shortened duration whole body F-FDG PET Patlak imaging on the Biograph Vision Quadra PET/CT using a population-averaged input function.在Biograph Vision Quadra PET/CT上使用群体平均输入函数进行缩短时长的全身F-FDG PET Patlak成像。
EJNMMI Phys. 2022 Oct 29;9(1):74. doi: 10.1186/s40658-022-00504-9.
6
The clinical utility of cfRNA for disease detection and surveillance: A proof of concept study in non-small cell lung cancer.cfRNA 用于疾病检测和监测的临床效用:非小细胞肺癌的概念验证研究。
Thorac Cancer. 2022 Aug;13(15):2180-2191. doi: 10.1111/1759-7714.14540. Epub 2022 Jun 16.
7
Short 2-[F]Fluoro-2-Deoxy-D-Glucose PET Dynamic Acquisition Protocol to Evaluate the Influx Rate Constant by Regional Patlak Graphical Analysis in Patients With Non-Small-Cell Lung Cancer.用于通过区域Patlak图形分析评估非小细胞肺癌患者流入速率常数的短时间2-[F]氟-2-脱氧-D-葡萄糖PET动态采集方案
Front Med (Lausanne). 2021 Nov 22;8:725387. doi: 10.3389/fmed.2021.725387. eCollection 2021.
8
Adaptive Fluorodeoxyglucose-Positron Emission Tomography Based Chemotherapy Selection for Metastatic Non-small Cell Lung Cancer.基于适应性氟脱氧葡萄糖正电子发射断层扫描的转移性非小细胞肺癌化疗选择
Cureus. 2021 Oct 15;13(10):e18804. doi: 10.7759/cureus.18804. eCollection 2021 Oct.
9
Photoacoustic imaging as a highly efficient and precise imaging strategy for the evaluation of brain diseases.光声成像作为一种用于评估脑部疾病的高效且精确的成像策略。
Quant Imaging Med Surg. 2021 May;11(5):2169-2186. doi: 10.21037/qims-20-845.
10
A new methodology to derive 3D kinetic parametric FDG PET images based on a mathematical approach integrating an error model of measurement.一种基于整合测量误差模型的数学方法来推导三维动态参数化FDG PET图像的新方法。
EJNMMI Res. 2018 Nov 15;8(1):99. doi: 10.1186/s13550-018-0454-9.